Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Interest Coverage Ratio (2020 - 2025)

Apellis Pharmaceuticals (APLS) has 6 years of Interest Coverage Ratio data on record, last reported at 4.71 in Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 155.77% year-over-year to 4.71; the TTM value through Dec 2025 reached 1.25, up 222.26%, while the annual FY2025 figure was 1.25, 222.26% up from the prior year.
  • Interest Coverage Ratio reached 4.71 in Q4 2025 per APLS's latest filing, down from 19.79 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 96.16 in Q4 2021 and bottomed at 56.09 in Q3 2021.
  • Average Interest Coverage Ratio over 5 years is 9.36, with a median of 13.26 recorded in 2023.
  • Peak YoY movement for Interest Coverage Ratio: plummeted 311.25% in 2021, then soared 624.46% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 96.16 in 2021, then tumbled by 122.05% to 21.2 in 2022, then skyrocketed by 46.14% to 11.42 in 2023, then skyrocketed by 174.04% to 8.45 in 2024, then tumbled by 155.77% to 4.71 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 4.71 in Q4 2025, 19.79 in Q3 2025, and 2.98 in Q2 2025.